Your browser doesn't support javascript.
loading
Final efficacy, immunogenicity, and safety analyses of a nine-valent human papillomavirus vaccine in women aged 16-26 years: a randomised, double-blind trial.
Huh, Warner K; Joura, Elmar A; Giuliano, Anna R; Iversen, Ole-Erik; de Andrade, Rosires Pereira; Ault, Kevin A; Bartholomew, Deborah; Cestero, Ramon M; Fedrizzi, Edison N; Hirschberg, Angelica L; Mayrand, Marie-Hélène; Ruiz-Sternberg, Angela Maria; Stapleton, Jack T; Wiley, Dorothy J; Ferenczy, Alex; Kurman, Robert; Ronnett, Brigitte M; Stoler, Mark H; Cuzick, Jack; Garland, Suzanne M; Kjaer, Susanne K; Bautista, Oliver M; Haupt, Richard; Moeller, Erin; Ritter, Michael; Roberts, Christine C; Shields, Christine; Luxembourg, Alain.
Afiliação
  • Huh WK; Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, AL, USA. Electronic address: whuh@uabmc.edu.
  • Joura EA; Department of Gynecology, Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria.
  • Giuliano AR; Center for Infection Research in Cancer, Moffitt Cancer Centre, Tampa, FL, USA.
  • Iversen OE; Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Gynecology and Obstetrics, Haukeland University Hospital, Bergen, Norway.
  • de Andrade RP; CERHFAC/Universidade Federal do Paraná, Setor de Ciências da Saúde, Departamento de Tocoginecologia, Paraná, Brazil.
  • Ault KA; Department of Obstetrics and Gynecology, University of Kansas Medical Center, Kansas City, KS, USA.
  • Bartholomew D; Department of Obstetrics and Gynecology, The Ohio State University Wexner Medical Center, Columbus, OH, USA.
  • Cestero RM; Department of Obstetrics and Gynecology, University of California Irvine School of Medicine, UC Irvine Health Orange, CA, USA.
  • Fedrizzi EN; Department of Obstetrics and Gynecology of The Federal University of Santa Catarina, Santa Catarina, Brazil.
  • Hirschberg AL; Department of Obstetrics and Gynecology, Karolinska University Hospital, Stockholm, Sweden; Department of Women's and Children's Health, Stockholm, Sweden.
  • Mayrand MH; Department of Obstetrics and Gynecology, University of Montreal, Montreal, QC, Canada; Centre de Recherche du Centre Hospitalier de l'Université de Montréal [CRCHUM], Montreal, QC, Canada.
  • Ruiz-Sternberg AM; Clinical Research Group, Universidad del Rosario, Bogota-Colombia.
  • Stapleton JT; Department of Internal Medicine, University of Iowa, Iowa City, IA, USA; Iowa City VA Medical Center, Iowa City, IA, USA.
  • Wiley DJ; School of Nursing, University of California, Los Angeles, CA, USA.
  • Ferenczy A; Department of Pathology, McGill University, Montreal, Quebec, Canada.
  • Kurman R; Department of Gynecology and Obstetrics, Johns Hopkins School of Medicine, Baltimore, MD, USA.
  • Ronnett BM; Department of Pathology, Johns Hopkins Medical Institution, Baltimore, MD, USA.
  • Stoler MH; Department of Pathology, University of Virginia School of Medicine Charlottesville, VA, USA.
  • Cuzick J; Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, UK.
  • Garland SM; The University of Melbourne, Department of Obstetrics and Gynaecology, The Royal Women's Hospital, University of Melbourne, Murdoch Childrens Research Institute, Melbourne, VIC, Australia.
  • Kjaer SK; Unit of Virus, Lifestyle and Genes, Danish Cancer Society and Department of Gynecology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Bautista OM; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Haupt R; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Moeller E; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Ritter M; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Roberts CC; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Shields C; Merck & Co, Inc, Kenilworth, NJ, USA.
  • Luxembourg A; Merck & Co, Inc, Kenilworth, NJ, USA.
Lancet ; 390(10108): 2143-2159, 2017 Nov 11.
Article em En | MEDLINE | ID: mdl-28886907
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cervical_cancer / 6_sense_organ_diseases Assunto principal: Neoplasias do Colo do Útero / Vacinação / Infecções por Papillomavirus / Papillomavirus Humano 6 / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 / 6_ODS3_enfermedades_notrasmisibles Problema de saúde: 2_enfermedades_transmissibles / 2_muertes_prematuras_enfermedades_notrasmisibles / 6_cervical_cancer / 6_sense_organ_diseases Assunto principal: Neoplasias do Colo do Útero / Vacinação / Infecções por Papillomavirus / Papillomavirus Humano 6 / Vacina Quadrivalente Recombinante contra HPV tipos 6, 11, 16, 18 / Imunogenicidade da Vacina Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Adolescent / Adult / Female / Humans Idioma: En Revista: Lancet Ano de publicação: 2017 Tipo de documento: Article